Novo Nordisk
NVO
#35
Rank
HK$2.142 T
Marketcap
HK$485.91
Share price
2.17%
Change (1 day)
-50.81%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

EPS for Novo Nordisk (NVO)

EPS in 2023 (TTM): HK$22.37

According to Novo Nordisk's latest financial reports the company's current EPS (TTM) is HK$22.16. In 2022 the company made an earnings per share (EPS) of HK$16.84 an increase over its 2021 EPS that were of HK$15.45.

EPS history for Novo Nordisk from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$22.3732.82%
2022HK$16.849.01%
2021HK$15.4515.08%
2020HK$13.4214.83%
2019HK$11.69-1.68%
2018HK$11.894.96%
2017HK$11.3331.08%
2016HK$8.64-10.33%
2015HK$9.6413.91%
2014HK$8.464.03%
2013HK$8.13-28.81%
2012HK$11.42108.9%
2011HK$5.4725.59%
2010HK$4.3535.01%
2009HK$3.22-9.17%
2008HK$3.5561.35%
2007HK$2.2028.96%
2006HK$1.7125.63%
2005HK$1.364.17%
2004HK$1.3013.55%
2003HK$1.1536.87%
2002HK$0.84-6.99%
2001HK$0.9021.56%
2000HK$0.7449.45%
1999HK$0.503.78%
1998HK$0.4812.15%
1997HK$0.4324.74%
1996HK$0.34

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
HK$14.43-34.87%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$42.12 90.12%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$30.80 39.02%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$24.67 11.36%๐Ÿ‡ซ๐Ÿ‡ท France